Galixir
星药科技
Galixir (星药科技) is an AI-driven drug discovery company that 5Y Capital has grouped under its "ITBT" (IT meets biotech) portfolio alongside peers such as XtalPi, NeoX, and METiS [^C?
]. The firm announced a nearly $10 million Pre-A round in August 2020 led jointly by Source Code Capital and DCM, with 5Y Capital (then Morningside) and Gaorong Capital also participating ; by December 2020 it had raised tens of millions of USD across two additional rounds backed by Redpoint China, 5Y Capital, and returning investors including Source Code and Gaorong . A further strategic round in August 2021 was led by the Shanghai AI Industry Investment Fund, with all existing shareholders reinvesting . Founder and CEO Licheng Tao was already representing the company at 5Y Capital-hosted ITBT forums by early 2021 [^C?
]. elsewhere's corpus does not contain more recent updates on its pipeline or funding since that 2021 round.
AI-generated — may contain errors, please verify.
Coverage
September, When Hope Will Break Through Like the Sun | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Galixir Completes New Strategic Funding Round, Continues Advancing Drug R&D Pipeline
5Y Capital continues to watch for opportunities where information technology can be applied in healthcare and medicine.
五源资本·5Y Talk | How Can Computing and AI Break Through the Traditional Paradigm of Drug Discovery?
Entering the Game, Direction, and the Future.
五源资本·5Y Capital's Xu Tian Jing: Why We're Bullish on Digital Pharmaceutical R&D | 5Y Talk
The ITBT track has a promising future ahead.
五源资本·5Y News | Galixir Announces Completion of Tens of Millions of USD in Funding, with Continued Backing from 5Y Capital
Breaking the Bottleneck in New Drug R&D with "AI+"
五源资本·5Y Capital's Xutian Jing: ITBT Sector Has a Promising Future, Poised to Produce a New Breed of Pharma Companies with Strong Cash-Generation Capabilities | Light View
ITBT is a long game, but when it succeeds, its contribution to human society is immense.
五源资本·What were the big moments for us last month? | Light Moments August Report
IPOs, Funding, Strategic Partnerships, Awards... August in Review
五源资本·The Collision of AI and Pharmaceuticals: Galaxy Pharma Tech Raises Nearly $10 Million in Funding | Light Moments
Galixir announced the completion of a nearly $10 million Pre-A funding round. The round was co-led by Source Code Capital and DCM, with 5Y Capital participating as a follow-on investor. Gaorong Capital, the lead investor in the company's angel round, continued to increase its stake.
五源资本·
